Glycemic efficacy of insulin icodec and risk factors for hypoglycemia in patients with type 2 diabetes mellitus: a real-world study

Frontiers in Physiology 2026 Open access

Read full text
Authors: Xiaodong Wanyan, Min Lin, Jianqing Tian, Y Y Lin
DOI: 10.3389/fphys.2026.1824651
Cited by: 1
References: 32

Abstract

Objective: To evaluate the real-world glycemic efficacy of Insulin Icodec in type 2 diabetes mellitus (T2DM) patients and identify independent risk factors for hypoglycemia. Methods: A retrospective cohort study enrolled 139 T2DM patients treated with Insulin Icodec (May 2024-December 2025). Glycemic efficacy was assessed by changes in HbA1c, fasting blood glucose (FBG), and target attainment rate (HbA1c

Fields of Study & Subjects

Diabetes Management and Research Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Frontiers in Physiology
Publisher
Frontiers Media SA
Volume
17
Pages
1824651–1824651
Publication date
11 May 2026
Language
EN